BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 28264886)

  • 1. CFTR gating: Invisible transitions made visible.
    Csanády L
    J Gen Physiol; 2017 Apr; 149(4):413-416. PubMed ID: 28264886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altering intracellular pH reveals the kinetic basis of intraburst gating in the CFTR Cl
    Chen JH; Xu W; Sheppard DN
    J Physiol; 2017 Feb; 595(4):1059-1076. PubMed ID: 27779763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator.
    Yu YC; Sohma Y; Hwang TC
    J Physiol; 2016 Jun; 594(12):3227-44. PubMed ID: 26846474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Changes Fundamental to Gating of the Cystic Fibrosis Transmembrane Conductance Regulator Anion Channel Pore.
    Linsdell P
    Adv Exp Med Biol; 2017; 925():13-32. PubMed ID: 27311317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stoichiometry and novel gating mechanism within the cystic fibrosis transmembrane conductance regulator channel.
    Qian F; Li T; Yang F; Liu L
    Exp Physiol; 2014 Dec; 99(12):1611-23. PubMed ID: 25326525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between permeation and gating in a putative pore domain mutant in the cystic fibrosis transmembrane conductance regulator.
    Zhang ZR; McDonough SI; McCarty NA
    Biophys J; 2000 Jul; 79(1):298-313. PubMed ID: 10866956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor Augments Mucociliary Clearance Abrogating Cystic Fibrosis Transmembrane Conductance Regulator Inhibition by Cigarette Smoke.
    Raju SV; Lin VY; Liu L; McNicholas CM; Karki S; Sloane PA; Tang L; Jackson PL; Wang W; Wilson L; Macon KJ; Mazur M; Kappes JC; DeLucas LJ; Barnes S; Kirk K; Tearney GJ; Rowe SM
    Am J Respir Cell Mol Biol; 2017 Jan; 56(1):99-108. PubMed ID: 27585394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the F508del mutation on ovine CFTR, a Cl- channel with enhanced conductance and ATP-dependent gating.
    Cai Z; Palmai-Pallag T; Khuituan P; Mutolo MJ; Boinot C; Liu B; Scott-Ward TS; Callebaut I; Harris A; Sheppard DN
    J Physiol; 2015 Jun; 593(11):2427-46. PubMed ID: 25763566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cystic fibrosis transmembrane conductance regulator phenylalanine 508 side chain in ion channel gating.
    Cui L; Aleksandrov L; Hou YX; Gentzsch M; Chen JH; Riordan JR; Aleksandrov AA
    J Physiol; 2006 Apr; 572(Pt 2):347-58. PubMed ID: 16484308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human epithelial cystic fibrosis transmembrane conductance regulator without exon 5 maintains partial chloride channel function in intracellular membranes.
    Xie J; Drumm ML; Zhao J; Ma J; Davis PB
    Biophys J; 1996 Dec; 71(6):3148-56. PubMed ID: 8968585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulfamoyl-4-oxoquinoline-3-carboxamides: novel potentiators of defective DeltaF508-cystic fibrosis transmembrane conductance regulator chloride channel gating.
    Suen YF; Robins L; Yang B; Verkman AS; Nantz MH; Kurth MJ
    Bioorg Med Chem Lett; 2006 Feb; 16(3):537-40. PubMed ID: 16288863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CFTR gating I: Characterization of the ATP-dependent gating of a phosphorylation-independent CFTR channel (DeltaR-CFTR).
    Bompadre SG; Ai T; Cho JH; Wang X; Sohma Y; Li M; Hwang TC
    J Gen Physiol; 2005 Apr; 125(4):361-75. PubMed ID: 15767295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conditional probability analysis of cystic fibrosis transmembrane conductance regulator gating indicates that ATP has multiple effects during the gating cycle.
    Hennager DJ; Ikuma M; Hoshi T; Welsh MJ
    Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3594-9. PubMed ID: 11248123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Walker mutations reveal loose relationship between catalytic and channel-gating activities of purified CFTR (cystic fibrosis transmembrane conductance regulator).
    Ramjeesingh M; Li C; Garami E; Huan LJ; Galley K; Wang Y; Bear CE
    Biochemistry; 1999 Feb; 38(5):1463-8. PubMed ID: 9931011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectification of cystic fibrosis transmembrane conductance regulator chloride channel mediated by extracellular divalent cations.
    Zhao J; Zerhusen B; Xie J; Drumm ML; Davis PB; Ma J
    Biophys J; 1996 Nov; 71(5):2458-66. PubMed ID: 8913585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting cystic fibrosis transmembrane conductance regulator structure and function.
    Hanrahan JW; Wioland MA
    Proc Am Thorac Soc; 2004; 1(1):17-21. PubMed ID: 16113406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploiting species differences to understand the CFTR Cl- channel.
    Bose SJ; Scott-Ward TS; Cai Z; Sheppard DN
    Biochem Soc Trans; 2015 Oct; 43(5):975-82. PubMed ID: 26517912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maximization of the rate of chloride conduction in the CFTR channel pore by ion-ion interactions.
    Gong X; Linsdell P
    Arch Biochem Biophys; 2004 Jun; 426(1):78-82. PubMed ID: 15130785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct block of the cystic fibrosis transmembrane conductance regulator Cl(-) channel by niflumic acid.
    Scott-Ward TS; Li H; Schmidt A; Cai Z; Sheppard DN
    Mol Membr Biol; 2004; 21(1):27-38. PubMed ID: 14668136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Butyl-p-hydroxybenzoate stimulates cystic fibrosis transmembrane conductance regulator Cl- transport].
    Ge H; Hou TT; Sun JJ; Yang H
    Yao Xue Xue Bao; 2009 Jan; 44(1):32-7. PubMed ID: 19350818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.